Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Butylchlorodihydroxytin: properties, applications and safety
Butylchlorodihydroxytin has valuable applications but requires adherence to safety guidelines due to potential hazards.
Dec 1,2023 APIIngenol: pharmacokinetic, mechanism of action and clinical applications
Ingenol, derived from Euphorbia peplus, shows promise in dermatology for its minimal systemic absorption and diverse therapeutic effects.
Dec 1,2023 APIHydroxychloroquine: mechanisms of action, pharmacokinetics and safety
Hydroxychloroquine has diverse mechanisms of action, pharmacokinetics, and potential adverse effects in treating autoimmune diseases.
Dec 1,2023 API5-Methyltetrahydrofolic acid: pharmacokinetics and physiological actions
5-Methyltetrahydrofolic acid is a crucial form of folate involved in absorption, distribution, metabolism, and excretion, regulating homocysteine levels.
Dec 1,2023 APIZirconium n-butoxide: versatile applications and safety
Zirconium n-butoxide enables the synthesis of versatile nanoparticles, composite sols, and unique thio/oxothio clusters, but requires strict safety precautions.
Dec 1,2023 APIABT-888: pharmacokinetic, mechanism of action and safety
ABT-888, a potent PARP inhibitor with favorable pharmacokinetics, shows promise in cancer therapy.
Dec 1,2023 APIEthyl 4-oxocyclohexanecarboxylate: properties, applications and safety
Ethyl 4-oxocyclohexanecarboxylate has unique properties for industrial use but requires careful safety management.
Dec 1,2023 APIEpiandrosterone: physiological effects and applications
Epiandrosterone, a natural steroid hormone, influences androgen levels, cognition, mood, and metabolic pathways.
Dec 1,2023 APIAcute Toxicologic Evaluation at p-Anisidine
p-Anisidine produced conjunctival injection, chemosis, and colorless diseharge. Miosis was observed from 15 min-2 hrs. Ocular effects disappeared in 1 eye at 72 hrs.
Dec 1,2023 API(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid: properties and applications
(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid is valued in biomedical and pharmaceutical research.
Dec 1,2023 API